IPO News | Suzhou Dongshan Precision (002384.SZ) Plans Hong Kong Listing; CSRC Requests Additional Details on Medical Device Production

Stock News
Jan 09

On January 9, the China Securities Regulatory Commission (CSRC) issued the "Requirements for Supplementary Materials for Overseas Listing Filing (January 5, 2026 - January 9, 2026)." The CSRC's International Department issued supplementary material requirements to a total of 10 companies, including a request for Suzhou Dongshan Precision Manufacturing Co.,Ltd. (002384.SZ) to provide additional explanations regarding matters such as its medical device production activities.

According to a disclosure made by the Hong Kong Stock Exchange on November 18, 2025, Suzhou Dongshan Precision Manufacturing Co.,Ltd. submitted an application to the main board of the Hong Kong Exchange. UBS Group AG, Haitong International, GF Securities, and CITIC Securities are acting as its joint sponsors.

The CSRC requested that Suzhou Dongshan Precision supplement the following items and instructed its legal counsel to verify and provide a clear legal opinion: Firstly, to provide additional details on the operational status of its businesses, including medical device production, commission agency services, information technology and socio-economic consulting services, the production, installation, and sale of solar product systems, and solar industrial technology research and consulting services, and to confirm whether all necessary qualifications and permits have been obtained.

Secondly, to clarify whether the business scope of the company and its subsidiaries involves areas listed in the "Special Administrative Measures for Foreign Investment Access (Negative List) (2024 Edition)."

Thirdly, to elaborate on whether the share pledges held by the company's controlling shareholder and actual controller before and after the completion of this offering could potentially lead to significant ownership disputes or result in a change of the company's controlling shareholder.

Fourthly, to provide details on the specific fulfillment of regulatory procedures, such as overseas investment and foreign exchange registration, involving the company's overseas subsidiaries, and to issue a conclusive opinion regarding compliance.

Fifthly, to supplement with detailed information on the company's overseas fundraising projects and the status of fulfilling overseas investment approval, verification, or filing procedures.

According to data from CIC Consulting, Suzhou Dongshan Precision is the world's largest supplier of PCBs for edge AI devices. Its products are primarily used in smartphones, personal computers, automobiles, industrial and IoT equipment, and it is rapidly expanding its capabilities into the data center end-market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10